Uzun O, Arikan S, Kocagöz S, Sancak B, Unal S
Section of Infectious Diseases, Department of MedicineHacettepe University School of Medicine, 06100, Ankara, Turkey.
Diagn Microbiol Infect Dis. 2000 Oct;38(2):101-7. doi: 10.1016/s0732-8893(00)00177-2.
Voriconazole is a promising azole effective against a variety of fungi, including yeasts. In this study, we tested in vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against some ATCC and reference strains and 250 clinical yeast isolates. We also evaluated the effect of time of reading on MIC results. Voriconazole was the most active agent against Candida and Trichosporon isolates, including the putatively fluconazole-resistant C. krusei (MIC(90) 0.25 microg/ml) and C. glabrata (MIC(90) 0.5 microg/ml). Amphotericin B MICs were scattered in a considerably narrow range in both RPMI 1640 and Antibiotic Medium 3. MICs at 24 hours and 48 hours were similar in general for all antifungals tested. The highest percentage of strains that showed 24-hour and 48-hour MICs within +/-1-log(2) dilution was observed for amphotericin B tested in RPMI (99%), and the lowest for amphotericin B tested in Antibiotic Medium 3 (80%). In conclusion, voriconazole is very effective against a wide spectrum of Candida species and 24-hour readings could substitute 48-hour MIC evaluation.
伏立康唑是一种有前景的唑类药物,对包括酵母菌在内的多种真菌有效。在本研究中,我们测试了伏立康唑、氟康唑、伊曲康唑和两性霉素B对一些美国典型培养物保藏中心(ATCC)菌株、参考菌株以及250株临床酵母菌分离株的体外活性。我们还评估了读数时间对最低抑菌浓度(MIC)结果的影响。伏立康唑是对念珠菌和毛孢子菌分离株最具活性的药物,包括假定对氟康唑耐药的克柔念珠菌(MIC90为0.25μg/ml)和光滑念珠菌(MIC90为0.5μg/ml)。在RPMI 1640培养基和3号抗生素培养基中,两性霉素B的MIC值分布范围相当窄。对于所有测试的抗真菌药物,24小时和48小时的MIC值总体上相似。在RPMI培养基中测试的两性霉素B,显示24小时和48小时MIC值在±1个对数2稀释范围内的菌株百分比最高(99%),而在3号抗生素培养基中测试的两性霉素B则最低(80%)。总之,伏立康唑对多种念珠菌非常有效,24小时读数可替代48小时的MIC评估。